Exploring the structural aspects of alanine racemase enzyme for antitubercular drug discovery – a computational approach
Background: Tuberculosis (TB) is a communicable disease that is a significant cause of ill health and one of the leading causes of death worldwide. The current antibiotics have been pivotal in managing TB to a greater extent. Still, the issue of antitubercular drug resistance is indeed a matter of c...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Creative Pharma Assent
2025-02-01
|
| Series: | Journal of Applied Pharmaceutical Research |
| Subjects: | |
| Online Access: | https://japtronline.com/index.php/joapr/article/view/783 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850043285548040192 |
|---|---|
| author | Unni Jayaram Parthan Anilkumar Fathima Rifana Yousuf Graceson Jose |
| author_facet | Unni Jayaram Parthan Anilkumar Fathima Rifana Yousuf Graceson Jose |
| author_sort | Unni Jayaram |
| collection | DOAJ |
| description | Background: Tuberculosis (TB) is a communicable disease that is a significant cause of ill health and one of the leading causes of death worldwide. The current antibiotics have been pivotal in managing TB to a greater extent. Still, the issue of antitubercular drug resistance is indeed a matter of concern and requires effective drug discovery strategies targeting less explored targets. One of the less explored but promising antitubercular targets, Alanine racemase (AlaR), a prokaryotic enzyme providing the essential peptidoglycan precursor D-alanine (D-Ala) in bacterial cell wall synthesis, is an attractive target for antitubercular drug discovery. Objective: The current study aims to explore the available protein targets of the AlaR enzyme in Mycobacterium tuberculosis and to understand the structural aspects to be followed in designing inhibitors for them. Methodology: As a part of the study, the crystal structure of the alanine racemase enzyme from Mycobacterium tuberculosis was subjected to computational studies using the Schrodinger drug design suite. The significant protocols followed involved protein preparation and fragment-based drug design studies. Results and discussion: The in-silico data suggested that substituted pteridine derivatives, which impart stable interaction at the active site of the alanine racemase enzyme, may be the potential lead moiety for drug design. Conclusion: Although the preliminary screening suggests that the pteridine ring system may be a promising lead, detailed in silico studies must be carried out, such as molecular mechanic generalized born surface area (MM-GBSA), density functional theory (DFT) studies, induced fit docking, molecular dynamics, etc. for further authentication. For effective correlation, detailed in vivo studies on AlaR enzyme inhibition can be carried out from a future perspective. |
| format | Article |
| id | doaj-art-71d323b2b8ed45408b22a82f814b7dd6 |
| institution | DOAJ |
| issn | 2348-0335 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Creative Pharma Assent |
| record_format | Article |
| series | Journal of Applied Pharmaceutical Research |
| spelling | doaj-art-71d323b2b8ed45408b22a82f814b7dd62025-08-20T02:55:16ZengCreative Pharma AssentJournal of Applied Pharmaceutical Research2348-03352025-02-01131384810.69857/joapr.v13i1.783784Exploring the structural aspects of alanine racemase enzyme for antitubercular drug discovery – a computational approachUnni Jayaram0Parthan Anilkumar1Fathima Rifana Yousuf2Graceson Jose3Department of Pharmaceutical Chemistry, Caritas College of Pharmacy, Ettumanoor – 686 631, Kerala, IndiaDepartment of Pharmaceutical Chemistry, Caritas College of Pharmacy, Ettumanoor – 686 631, Kerala, IndiaDepartment of Pharmaceutical Chemistry, Caritas College of Pharmacy, Ettumanoor – 686 631, Kerala, IndiaDepartment of Pharmaceutical Chemistry, Caritas College of Pharmacy, Ettumanoor – 686 631, Kerala, IndiaBackground: Tuberculosis (TB) is a communicable disease that is a significant cause of ill health and one of the leading causes of death worldwide. The current antibiotics have been pivotal in managing TB to a greater extent. Still, the issue of antitubercular drug resistance is indeed a matter of concern and requires effective drug discovery strategies targeting less explored targets. One of the less explored but promising antitubercular targets, Alanine racemase (AlaR), a prokaryotic enzyme providing the essential peptidoglycan precursor D-alanine (D-Ala) in bacterial cell wall synthesis, is an attractive target for antitubercular drug discovery. Objective: The current study aims to explore the available protein targets of the AlaR enzyme in Mycobacterium tuberculosis and to understand the structural aspects to be followed in designing inhibitors for them. Methodology: As a part of the study, the crystal structure of the alanine racemase enzyme from Mycobacterium tuberculosis was subjected to computational studies using the Schrodinger drug design suite. The significant protocols followed involved protein preparation and fragment-based drug design studies. Results and discussion: The in-silico data suggested that substituted pteridine derivatives, which impart stable interaction at the active site of the alanine racemase enzyme, may be the potential lead moiety for drug design. Conclusion: Although the preliminary screening suggests that the pteridine ring system may be a promising lead, detailed in silico studies must be carried out, such as molecular mechanic generalized born surface area (MM-GBSA), density functional theory (DFT) studies, induced fit docking, molecular dynamics, etc. for further authentication. For effective correlation, detailed in vivo studies on AlaR enzyme inhibition can be carried out from a future perspective.https://japtronline.com/index.php/joapr/article/view/783alanine racemasetuberculosismycobacterium tuberculosisprotein crystal structureantitubercular agents |
| spellingShingle | Unni Jayaram Parthan Anilkumar Fathima Rifana Yousuf Graceson Jose Exploring the structural aspects of alanine racemase enzyme for antitubercular drug discovery – a computational approach Journal of Applied Pharmaceutical Research alanine racemase tuberculosis mycobacterium tuberculosis protein crystal structure antitubercular agents |
| title | Exploring the structural aspects of alanine racemase enzyme for antitubercular drug discovery – a computational approach |
| title_full | Exploring the structural aspects of alanine racemase enzyme for antitubercular drug discovery – a computational approach |
| title_fullStr | Exploring the structural aspects of alanine racemase enzyme for antitubercular drug discovery – a computational approach |
| title_full_unstemmed | Exploring the structural aspects of alanine racemase enzyme for antitubercular drug discovery – a computational approach |
| title_short | Exploring the structural aspects of alanine racemase enzyme for antitubercular drug discovery – a computational approach |
| title_sort | exploring the structural aspects of alanine racemase enzyme for antitubercular drug discovery a computational approach |
| topic | alanine racemase tuberculosis mycobacterium tuberculosis protein crystal structure antitubercular agents |
| url | https://japtronline.com/index.php/joapr/article/view/783 |
| work_keys_str_mv | AT unnijayaram exploringthestructuralaspectsofalanineracemaseenzymeforantituberculardrugdiscoveryacomputationalapproach AT parthananilkumar exploringthestructuralaspectsofalanineracemaseenzymeforantituberculardrugdiscoveryacomputationalapproach AT fathimarifanayousuf exploringthestructuralaspectsofalanineracemaseenzymeforantituberculardrugdiscoveryacomputationalapproach AT gracesonjose exploringthestructuralaspectsofalanineracemaseenzymeforantituberculardrugdiscoveryacomputationalapproach |